RE-BVS – Piemonte Repository

Sfoglia per AUTORE
HAN J
Collezione AOU San Luigi di Orbassano

Items : 4

Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2024 Oct 20;42(30):3593-3605. doi: 10.1200/JCO.24.01001. Epub 2024 Jun 10.

2024
AOU San Luigi di Orbassano

Leighl NB; Akamatsu H; Lim SM; Cheng Y; Minchom AR; Marmarelis ME; Sanborn RE; Chih-Hsin Yang J; Liu B; John T; Massutí B; Spira AI; Lee SH; Wang J; Li J; Liu C; Novello S; Kondo M; Tamiya M; Korbenfeld E; Moskovitz M; Han JY; Alexander M; Joshi R; Felip E; Voon PJ; Danchaivijitr P; Hsu PC; Silva Melo Cruz FJ; et alii...

HDAC7 promotes NSCLC proliferation and metastasis via stabilization by deubiquitinase USP10 and activation of ?-catenin-FGF18 pathway. in Journal of experimental & clinical cancer research : CR / J Exp Clin Cancer Res. 2022 Mar 11;41(1):91. doi: 10.1186/s13046-022-02266-9.

2022
AOU San Luigi di Orbassano

Guo K; Ma Z; Zhang Y; Han L; Shao C; Feng Y; Gao F; Di S; Zhang Z; Zhang J; Tabbò F; Ekman S; Suda K; Cappuzzo F; Han J; Li X; Yan X;

Benefit of Extended Dual Antiplatelet Therapy Duration in Acute Coronary Syndrome Patients Treated with Drug Eluting Stents for Coronary Bifurcation Lesions (from the BIFURCAT Registry). in The American journal of cardiology / Am J Cardiol. 2021 Oct 1;156:16-23. doi: 10.1016/j.amjcard.2021.07.005. Epub 2021 Aug 2.

2021
ASL Città di Torino
AOU San Luigi di Orbassano

Dusi V; Cortese B; Imori Y; Trabattoni D; Capodanno D; Gallone G; Nam CW; Muscoli S; Hong SJ; Truffa Giachet A; Doh JH; Helft G; Choi KH; Escaned J; Song YB; di Mario C; Han SH; Cerrato E; Hur SH; Smolka G; Chun WJ; Iannaccone M; Gwon HC; De Luca L; Kim HS; Parma R; Park KW; Patti G; Yang HM; et alii...

Long-Term Outcomes and Retreatment Among Patients With Previously Treated, Programmed Death-Ligand 1?Positive, Advanced Non?Small-Cell Lung Cancer in the KEYNOTE-010 Study. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2020 May 10;38(14):1580-1590. doi: 10.1200/JCO.19.02446. Epub 2020 Feb 20.

2020
AOU San Luigi di Orbassano

Herbst RS; Garon EB; Kim DW; Cho BC; Perez-Gracia JL; Han JY; Arvis CD; Majem M; Forster MD; Monnet I; Novello S; Szalai Z; Gubens MA; Su WC; Ceresoli GL; Samkari A; Jensen EH; Lubiniecki GM; Baas P;